FEB 06, 2021 9:34 AM PST

Chronic Depression Linked to Reduced Support Cell Function in Brain

WRITTEN BY: Annie Lennon

Researchers from Canada have found that people with chronic depression who ultimately commit suicide have significantly fewer levels of certain supportive nerve cells in the brain compared to people with no mental health diagnosis.

For the study, the researchers examined astrocytes- a kind of support cell in the brain that distributes nutrients, keeps charged molecules in balance, and heals trauma to the brain and spinal cord. Previously, researchers found that a protein called glial fibrillary acidic protein (GFAP) isn't expressed in as high quantities by astrocytes in brains diagnosed with depression than those without.

As astrocytes that produce GFAP are a minority of the overall astrocyte population, the researchers set out to identify other features of astrocytes that may influence depression. In this case, the researchers set out to map vimentin, another kind of protein found in astrocytes. To do so, they analyzed brain tissue from 10 men diagnosed with depression who passed away from suicide. They then compared these samples with those from 10 men who died suddenly with no mental health diagnosis. 

In doing so, they found that, like with GFAP-producing astrocytes, vimentin-expressing astrocytes were significantly fewer among brain tissue samples taken from men with depression than those without. Moreover, they found that men diagnosed with depression had twice as few vimentin cells than GFAP cells in the prefrontal cortex. The findings suggest that vimentin likely plays a significant role in chronic depression. How these proteins influence depression, however, and why they decline in number, remains unknown. 

"The promising news is that unlike neurons, the adult human brain continually produces many new astrocytes," says senior author of the research, Naguib Mechawar. "Finding ways that strengthen these natural brain functions may improve symptoms in depressed individuals."

 

Sources: Science AlertFrontiers in Psychiatry

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 17, 2020
Drug Discovery & Development
Molecular Mechanism Behind Ketamine for Depression Discovered
DEC 17, 2020
Molecular Mechanism Behind Ketamine for Depression Discovered
Over 30% of people with major depressive disorder are resistant to serotonin reuptake inhibitors (SSRI's), the curre ...
DEC 17, 2020
Neuroscience
Coding and Language Use Different Parts of the Brain
DEC 17, 2020
Coding and Language Use Different Parts of the Brain
Neuroscientists from MIT have found that reading computer code does not activate the areas in the brain used to process ...
DEC 29, 2020
Cannabis Sciences
What Happens When You Combine Cannabis with Psychedelics?
DEC 29, 2020
What Happens When You Combine Cannabis with Psychedelics?
Despite the growing popularity of cannabis and psychedelics, there is a shortage of research on how the two interact. Be ...
JAN 09, 2021
Cannabis Sciences
Over 50% on Medical Cannabis Experience Withdrawal Symptoms
JAN 09, 2021
Over 50% on Medical Cannabis Experience Withdrawal Symptoms
A new study has found that over half of people who use medical cannabis products for pain relief experience multiple wit ...
MAR 11, 2021
Clinical & Molecular DX
Racial Disparities in ADHD Diagnoses
MAR 11, 2021
Racial Disparities in ADHD Diagnoses
Researchers have found significant racial disparities in ADHD diagnoses and treatment: Black, Hispanic, and Asian childr ...
APR 15, 2021
Drug Discovery & Development
Magic Mushroom Therapy and Antidepressants Produce Similar Results
APR 15, 2021
Magic Mushroom Therapy and Antidepressants Produce Similar Results
In recent years, psilocybin (the psychoactive ingredient in 'magic mushrooms') has gained increasing amounts of ...
Loading Comments...